Patient Perception Study for AL-4943A
NCT01294969
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Conjunctivitis
Interventions
DRUG:
AL-4943A
Sponsor
Alcon Research